RESUMEN
PURPOSE: We aimed to investigate controversial pediatric urolithiasis issues systematically, integrating expert consensus and comprehensive guidelines reviews. METHODS: Two semi-structured online focus group meetings were conducted to discuss the study's need and content, review current literature, and prepare the initial survey. Data were collected through surveys and focus group discussions. Existing guidelines were reviewed, and a second survey was conducted using the Delphi method to validate findings and facilitate consensus. The primary outcome measures investigated controversial issues, integrating expert consensus and guideline reviews. RESULTS: Experts from 15 countries participated, including 20 with 16+ years of experience, 2 with 11-15 years, and 4 with 6-10 years. The initial survey identified nine main themes, emphasizing the need for standardized diagnostic and treatment protocols and tailored treatments. Inter-rater reliability was high, with controversies in treatment approaches (score 4.6, 92% agreement), follow-up protocols (score 4.8, 100% agreement), and diagnostic criteria (score 4.6, 92% agreement). The second survey underscored the critical need for consensus on identification, diagnostic criteria (score 4.6, 92% agreement), and standardized follow-up protocols (score 4.8, 100% agreement). CONCLUSION: The importance of personalized treatment in pediatric urolithiasis is clear. Prioritizing low-radiation diagnostic tools, effectively managing residual stone fragments, and standardized follow-up protocols are crucial for improving patient outcomes. Integrating new technologies while ensuring safety and reliability is also essential. Harmonizing guidelines across regions can provide consistent and effective management. Future efforts should focus on collaborative research, specialized training, and the integration of new technologies in treatment protocols.
Asunto(s)
Guías de Práctica Clínica como Asunto , Urolitiasis , Humanos , Niño , Urolitiasis/terapia , Urolitiasis/diagnóstico , Consenso , Técnica DelphiRESUMEN
BACKGROUND AND OBJECTIVES: As a result of technical innovation, i.e., improvement of seed quality, implantation method, and dose calculation, it has been possible to continuously improve oncological results in the treatment of localized prostate cancer with low-dose-rate brachytherapy (LDR-BT). Randomized controlled trials have shown that there is no significant difference in oncological control between the use of radical prostatectomy and LDR-BT in patients with low-risk prostate cancer. The objective of this study was to investigate the oncological efficacy of LDR-BT. MATERIALS AND METHODS: A retrospective multicenter analysis was conducted on 618 patients treated with LDR-BT as monotherapy, who received a dose of 145â¯Gy. We used iodine125 as the radioactive source. The analysis was conducted with follow-up data from two brachytherapy centers in Germany between 2004 and 2019. The primary endpoint was biochemical relapse-free survival (bRFS), whereby the Phoenix definition (PSAâ¯-â¯nadirâ¯+2â¯ng/ml; PSA: prostate-specific antigen) was used to define biochemical relapse, i.e., therapeutic failure. RESULTS: Median follow-up was 52 months (range 3-180 months). The bRFS across all risk groups was 87.87%. Oncological efficacy was significantly higher in patients with a Gleason score of 6 and 7a (p-valueâ¯<â¯0.0001); however, there was no significant difference in bRFS between these two groups. Bilateral tumor infiltration or prostate volume had no significant influence on bRFS. CONCLUSION: Our results show no difference in bRFS between Gleason score 6 and 7a.
RESUMEN
The coronavirus has challenged all medical systems worldwide. Herein both waves of COVID-19 (coronavirus disease 2019) in spring and autumn 2020 differ principally. Whereas Europe was hit by the first wave more or less unprepared, which was aggravated by the high virulence of COVID-19, the second wave is characterized by a much higher contagiosity of the virus with very high incidences. On the other hand the virus has attenuated, which is reflected by the significantly lower incidence-related mortality rate. However, the overall increasing number of infected patients represents again a great challenge for the medical management of the disease. France and Spain are doing better in comparison to Germany and Italy this time. The absolute number of deaths per week is higher than during the peak of the first wave. However, urologists in these countries have also experienced greater restrictions in their activities in the second shutdown than in Germany, where there is only a reduction of beds to between 75 and 90%. Mostly all levels are operated. Of importance for Germany, however, is the plateau on a high level for several weeks probably due to the reduced efficacy of a light lock-down. This finally resulted in a total lock-down in mid-December 2020. Subsequently in Germany some hospitals are also reaching their limits with similar consequences for the departments of urology facing a 50% reduction of beds and operating only level III and IV indications. Nevertheless, the management of urologic patients during the COVID-19 pandemic is carried out in Europa on a high standard. Therefor the risk of secondary harm to our patients is expected to be rather minimal in the long run.
Asunto(s)
COVID-19 , Urología , Control de Enfermedades Transmisibles , Europa (Continente) , Francia , Alemania/epidemiología , Humanos , Italia , Pandemias , SARS-CoV-2RESUMEN
Urology has always been closely linked to technological progress. In the last few decades, we have witnessed increasing implementation of various technologies and innovations in subdisciplines of urology. While conventional laparoscopy is increasingly being replaced by robot-assisted procedures and the introduction of new robotic systems from various manufactures will continue for years, the field of endourolgy is still not dominated by robotic systems. However, new systems (e.g., autonomous, robot-controlled aquablation of the prostate) are becoming increasingly popular and numerous development projects will also probably change clinical care in coming years. In addition, further advancements in the combination of robotics with intraoperative navigation through the integration of imaging and augmented-reality (AR) and virtual reality (VR) technology can be expected. This combination of navigation and robotic technology is already being used successfully in prostate biopsy.
Asunto(s)
Laparoscopía , Robótica , Cirugía Asistida por Computador , Urología , Humanos , Masculino , PróstataRESUMEN
Minimally invasive surgery, which became an elementary part of urologic surgery at the beginning of the 1990s, is associated with clear advantages for patients such as increased cosmesis, decreased blood loss, less postoperative pain, and faster patient recovery. Increasing experience was associated with comparable operative outcomes to open surgery, and more recently better oncologic and functional results with minimally invasive surgical techniques as shown in large studies in the literature. Robotic surgery was introduced at the beginning of 2000 and has facilitated minimally invasive surgery. Robotic assisted laparoscopic operations (e.g., radical prostatectomy or partial nephrectomy) have evolved rapidly to become widely accepted procedures. However, robotic surgery was monopolized by one company, namely Intuitive Surgical which owns the majority of the patents in this field. The market and the interest were growing, but unfortunately the prices were rising and exceeded 2 million Euros. This reality has been the main obstacle for many clinics who wanted to adopt robotic surgery. In recent years, new companies have developed and patented alternative robotic surgical systems after earlier patents of Intuitive Surgical expired. Thus, real competition could start in the robotic market. In this article, we introduce these new robotic platforms for urologic surgery.
Asunto(s)
Procedimientos Quirúrgicos Robotizados , Procedimientos Quirúrgicos Urológicos/métodos , Urología/tendencias , Humanos , Laparoscopía , Masculino , Prostatectomía , Procedimientos Quirúrgicos Robotizados/tendencias , Robótica , Procedimientos Quirúrgicos Urológicos/tendenciasRESUMEN
PURPOSE: To compare iPad-assisted (Apple Inc., Cupertino, USA) percutaneous access to the kidney to the standard puncturing technique for percutaneous nephrolithotomy (PCNL). METHODS: For the iPad-assisted PCNL, a computed tomography is performed prior to surgery, using fiducial radiopaque markers. The important anatomical structures (i.e. kidney, stones) are segmented using specific software enabling the superimposition of images semi-transparently on the iPad by marker-based navigation. Twenty-two patients underwent an iPad-assisted percutaneous puncture of the kidney for PCNL. Twenty-two patients of the clinical database from the Urological Department SLK Hospital Heilbronn, who underwent the standard puncturing technique, were matched to these patients. Matching criteria were age, gender, stone volume, body mass index, stone site and the absence of anatomical variation. Puncture time, radiation exposure and number of attempts for a successful puncture were evaluated. All procedures were performed by two experienced urologists. The standard puncturing method consisted of a combination of ultrasound and fluoroscopy guidance. Chi-square and t test were used to ensure that there was no difference in the matching criteria between the groups. To compare the two methods, U test, Kruskal-Wallis and Chi-square test were used. RESULTS: Examination of radiation exposure showed a significant difference between the two groups in favour of the standard puncturing method (p < 0.01) and puncture time (p = 0.01). However, there was no significant difference in puncturing attempts (p = 0.45). CONCLUSION: The iPad-assisted navigation, with the objective being to puncture the renal collecting system, represents a new technique (IDEAL criteria 2b), which proved to be applicable in clinical practice, but still has potential for technical improvement.
Asunto(s)
Computadoras de Mano , Cálculos Renales/cirugía , Nefrolitotomía Percutánea/métodos , Cirugía Asistida por Computador/métodos , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Análisis por Apareamiento , Persona de Mediana Edad , Ultrasonografía , Adulto JovenRESUMEN
Both the demographic shift and progress in medicine are resulting in an increasingly longer life expectancy. It is presumed that a mean age of 90 years will be achieved within the next decade in many countries. Thus, geriatric medicine, which is committed to the specific needs of older, often frail and frequently comorbid patients, is becoming increasingly more important. The prevalence of infections of the genitourinary tract increases with age, simultaneously, a critical and conscious use of antibiotics is required in terms of antimicrobial treatment. The intention of the present review is to make the reader aware of the specific characteristics of urinary tract infections and asymptomatic bacteriuria in the older patient population in terms of epidemiology, spectrum of pathogens and resistance as well as the indications for and performance of antimicrobial treatment.
Asunto(s)
Antibacterianos/uso terapéutico , Infecciones Urinarias/tratamiento farmacológico , Anciano , Anciano de 80 o más Años , Profilaxis Antibiótica/métodos , Bacteriuria/tratamiento farmacológico , Humanos , Resultado del TratamientoRESUMEN
The spectrum of surgical procedures for the minimally invasive treatment of benign prostatic hyperplasia (BPH) has significantly increased over the last two decades. The simple suprapubic prostatectomy (subtotal prostatectomy, SP) has largely lost relevance in current practice. On the other hand, transurethral resection of the prostate (TURP) has been further standardized and potentially made safer by the introduction of the bipolar technique and low-pressure systems.Transurethral (endoscopic) enucleation techniques (endoscopic enucleation of the prostate, EEP) are increasingly competing with the current gold standard TURP and are replacing SP for treatment of larger adenomas. This approach is especially related to the rapid development of laser technology, which has sustainably changed the face of modern BPH treatment in a similar way to stone therapy. This has been incorporated in the clinical patient management, clinical studies and standardization of numerous surgical techniques that are systematically described in this article. Additionally, efforts have also been made to use other energy sources, such as bipolar current in EEP. With respect to scientific objectivity, high-quality clinical trials are regularly published which further strengthen the position of EEP.
Asunto(s)
Terapia por Láser , Hiperplasia Prostática , Resección Transuretral de la Próstata , Endoscopía , Humanos , Masculino , Prostatectomía , Hiperplasia Prostática/terapiaRESUMEN
PURPOSE: Aquablation of the prostate using the AquaBeam™ system promises equivalent functional outcomes, reduced learning curve, and improved sexual function compared to transurethral prostate resection as shown in prospective randomized trials. This prospective cohort study aims to evaluate if published results can be transferred into the clinical routine in a non-selected patient collective. METHODS: This study includes all patients treated between September 2017 and June 2018 with Aquablation of the prostate. Patients have been evaluated prospectively for the perioperative course and early follow-up. Besides voiding parameter and symptom score, TRUS-volume change, ejaculatory function, and adverse events have been recorded. RESULTS: 118 consecutive patients have been treated in the given time. Aquablation could be carried out successfully in all patients. IPSS, QoL, Qmax, and PVR improved significantly after the procedure and continued to improve during 3-month follow-up. Mean OR time was 20 min, TRUS volume decreased by 65%, and 73% of the patients retained antegrade ejaculation. Thirteen adverse events (> Clavien-Dindo I) occurred in 10 patients. CONCLUSION: The surgical ablation of the prostate using Aquablation achieved significant and immediate improvement of functional voiding parameters Qmax and PVR as well as symptomatic improvement of IPSS and QoL. Aquablation seems to be safe and effective with a low perioperative complication profile even in a non-selected group of patients.
Asunto(s)
Técnicas de Ablación/métodos , Hiperplasia Prostática/cirugía , Resección Transuretral de la Próstata/métodos , Obstrucción Uretral/cirugía , Agua , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/epidemiología , Hiperplasia Prostática/complicaciones , Disfunciones Sexuales Fisiológicas/epidemiología , Resultado del Tratamiento , Obstrucción Uretral/etiologíaRESUMEN
The monopoly of robotic surgical devices of the last 15 years will end in 2019 when key patents of Intuitive Surgical expire. Thus, we can expect an interesting competitive situation in the coming years. Based on personal experience with robot-assisted surgery since 2001, we conducted a search of the current literature together with a search of relevant patents in this field. Finally, we visited the websites of manufacturers of existing and future robotic surgical devices with possible applications in urology. Such devices have to prove that they meet the high-quality standard of the current Da Vinci series (SI, X, XI). For this purpose, we propose to classify the main features of the different devices, such as type of console (closed/open), arrangement of robotic arms (single/multiple carts/attached to operating room table), type of three-dimensional videosystem (by mirror/ocular/using polarizing glasses) or degrees of freedom (DOF) of end effectors (5 vs. 7 DOF). In the meantime, there are also robotic systems used in endourology: Avicenna Roboflex® and the AquaBeam® system for robot-assisted aquablation therapy of the prostate. While Roboflex® improves the ergonomics of flexible ureteroscopy-similar to the Da Vinci robot, AquaBeam® may for the first time eliminate the surgeon, who might only be needed to manage severe postoperative bleeding.
Asunto(s)
Laparoscopía , Procedimientos Quirúrgicos Robotizados/métodos , Procedimientos Quirúrgicos Robotizados/tendencias , Ureteroscopía/métodos , Procedimientos Quirúrgicos Urológicos/tendencias , Urología/tendencias , Endoscopía , Ergonomía , Humanos , Laparoscopía/tendencias , Masculino , Cirugía Asistida por Video/tendenciasRESUMEN
Interventional treatment of stones essentially consists of three treatment modalities. Extracorporeal shockwave lithotripsy (ESWL), in addition to uterorenoscopy (URS) and percutaneous nephrolitholapaxy (PCNL) is an essential treatment pillar and is the only noninvasive therapy option for the treatment of urinary stones. After a long period of ESWL being the leading choice in stone treatment, the number of SWL interventions diminished in recent years in favor of the other two treatment modalities (URS and PCNL). This article describes the indications, surgical technique and management of complications of SWL.
Asunto(s)
Cálculos Renales/terapia , Litotricia/métodos , Profilaxis Antibiótica , Contraindicaciones , Femenino , Humanos , Masculino , Procedimientos Quirúrgicos Mínimamente Invasivos , Nefrolitotomía Percutánea , UreteroscopíaRESUMEN
Correct positioning of patients during preoperative preparations is essential for success of the intervention to avoid any positioning trauma and to provide the best access to the targeted structures. The appropriate positioning (and optimal performance) means that complications are avoided and also makes an essential contribution to the smooth course of the surgical intervention. A correct position is essential particularly in urology because the organs assigned to the discipline of urology are anatomically mostly difficult to reach. A further important function of the correct positioning technique is the avoidance of injuries to the patient. This article summarizes the most common positioning techniques in urological interventions with special emphasis on the explanation of practical advice, helpful tips and possible complications that can enable even junior surgeons to correctly perform the appropriate positioning technique.
Asunto(s)
Posicionamiento del Paciente/métodos , Enfermedades Urológicas/cirugía , Procedimientos Quirúrgicos Urológicos/métodos , Diseño de Equipo , Femenino , Humanos , Complicaciones Intraoperatorias/prevención & control , Masculino , Mesas de Operaciones , Posicionamiento del Paciente/instrumentación , Complicaciones Posoperatorias/prevención & control , Cuidados Preoperatorios/métodosRESUMEN
Secondary bladder neck sclerosis represents one of the more frequent complications following endoscopic, open, and other forms of minimally invasive prostate surgery. Therapeutic decisions depend on the type of previous intervention (e.g., radical prostatectomy, TURP, HoLEP, radiotherapy, HIFU) and on associated complications (e.g., incontinence, fistula). Primary treatment in most cases represents an endoscopic bilateral incision. No specific advantages of any type of the applied energy (i.e., mono-/bipolar HF current, cold incision, holmium/thulium YAG laser) could be documented. Adjuvant measures such as injection of corticosteroids or mitomycin C have not been helpful in clinical routine. In case of first recurrence, a transurethral monopolar or bipolar resection can usually be performed. Recently, the ablation of the scared tissue using bipolar vaporization has been recommended providing slightly better long-term results. Thereafter, surgical reconstruction is strongly recommended using an open, laparoscopic, or robot-assisted approach. Depending on the extent of the bladder neck sclerosis and the underlying prostate surgery, a Y-V/T-plasty, urethral reanastomosis, or even a radical prostatectomy with new urethravesical anastomosis should be performed. Stent implantation should be reserved for patients who are not suitable for surgery. The final palliative measure is a cystectomy with urinary diversion or a (continent) cystostomy.
Asunto(s)
Terapia por Láser , Complicaciones Posoperatorias/patología , Prostatectomía , Resección Transuretral de la Próstata , Obstrucción del Cuello de la Vejiga Urinaria/patología , Vejiga Urinaria/cirugía , Humanos , Masculino , Complicaciones Posoperatorias/cirugía , Reoperación , Factores de Riesgo , Esclerosis , Obstrucción del Cuello de la Vejiga Urinaria/cirugíaRESUMEN
The landscape of the surgical management of urologic malignancies has dramatically changed over the past 20 years. On one side, better diagnostic and prognostic tools allowed better patient selection and more reliable surgical planning. On the other hand, the implementation of minimally invasive techniques and technologies, such as robot-assisted laparoscopy surgery and image-guided surgery, allowed minimizing surgical morbidity. Ultimately, these advances have translated into a more tailored approach to the management of urologic cancer patients. Following the paradigm of "precision medicine", contemporary urologic surgery has entered a technology-driven era of "precision surgery", which entails a range of surgical procedures tailored to combine maximal treatment efficacy with minimal impact on patient function and health related quality of life. Aim of this non-systematic review is to provide a critical analysis of the most recent advances in the field of surgical uro-oncology, and to define the current and future role of "precision surgery" in the management of genitourinary cancers.
Asunto(s)
Cistectomía/métodos , Neoplasias Renales/cirugía , Nefrectomía/métodos , Medicina de Precisión , Prostatectomía/métodos , Neoplasias de la Próstata/cirugía , Neoplasias de la Vejiga Urinaria/cirugía , Humanos , Laparoscopía , Masculino , Tratamientos Conservadores del Órgano , Prostatectomía/efectos adversos , Neoplasias de la Próstata/diagnóstico por imagen , Procedimientos Quirúrgicos Robotizados , Neoplasias de la Vejiga Urinaria/diagnóstico por imagenRESUMEN
Ureterorenoscopy (URS) is a minimally invasive treatment option for removal of kidney stones, which has gained importance in this field over the past two decades. This technique has replaced extracorporeal shock wave lithotripsy (ESWL) stone surgery for many indications. It is also particularly important in the diagnostics and treatment for tumors of the upper urinary tract. This article describes the indications, surgical technique and management of complications of URS.
Asunto(s)
Cálculos Renales/patología , Cálculos Renales/cirugía , Procedimientos Quirúrgicos Mínimamente Invasivos/métodos , Ureteroscopía/métodos , Neoplasias Urológicas/patología , Neoplasias Urológicas/cirugía , Medicina Basada en la Evidencia , Humanos , Procedimientos Quirúrgicos Mínimamente Invasivos/instrumentación , Resultado del Tratamiento , Ureteroscopía/efectos adversos , Ureteroscopía/instrumentaciónRESUMEN
Percutaneous nephrolithotomy (PCNL) is a well-established minimally invasive treatment option for removal of kidney stones. This technique has now replaced open stone surgery for virtually all indications. This article describes the indications, the surgical technique and the complication management of PCNL.
Asunto(s)
Cálculos Renales/cirugía , Nefrostomía Percutánea/efectos adversos , Nefrostomía Percutánea/métodos , Complicaciones Posoperatorias/etiología , Medicina Basada en la Evidencia , Alemania , Humanos , Cálculos Renales/diagnóstico , Procedimientos Quirúrgicos Mínimamente Invasivos/efectos adversos , Procedimientos Quirúrgicos Mínimamente Invasivos/métodos , Complicaciones Posoperatorias/prevención & control , Resultado del TratamientoAsunto(s)
Neoplasias de las Glándulas Suprarrenales/cirugía , Adrenalectomía/métodos , Adenoma Corticosuprarrenal/cirugía , Carcinoma/cirugía , Laparoscopía/métodos , Síndromes Paraneoplásicos Endocrinos/cirugía , Feocromocitoma/cirugía , Neoplasias de las Glándulas Suprarrenales/diagnóstico , Neoplasias de las Glándulas Suprarrenales/secundario , Adrenalectomía/instrumentación , Adenoma Corticosuprarrenal/diagnóstico , Carcinoma/diagnóstico , Humanos , Laparoscopía/instrumentación , Síndromes Paraneoplásicos Endocrinos/diagnóstico , Posicionamiento del Paciente , Feocromocitoma/diagnóstico , Cuidados Preoperatorios , Espacio Retroperitoneal/cirugía , Instrumentos QuirúrgicosRESUMEN
PURPOSE: We compare bipolar vs monopolar transurethral prostate resection safety/secondary outcomes including efficacy in patients with large prostate volume or severe lower urinary tract symptoms. MATERIALS AND METHODS: From July 2006 to June 2009 candidates for transurethral prostate resection were recruited at 4 centers, randomized 1:1 into monopolar/bipolar transurethral prostate resection arms and followed up to 36 months. Post hoc data analysis from patients with large prostate volume or severe lower urinary tract symptoms is presented. Patients with large prostate volume or severe lower urinary tract symptoms were defined as those with transrectal ultrasound based prostate volume greater than 80 ml or International Prostate Symptom Score greater than 19. Safety was estimated using sodium/hemoglobin changes immediately after surgery, complications during the early postoperative period (up to 6 weeks), and short-term (up to 12 months) and midterm (up to 36 months) followup. Secondary outcomes included, among others, efficacy quantified by changes in maximum urine flow rate, post-void residual urine volume and International Prostate Symptom Score compared with baseline. RESULTS: A total of 279 patients were randomized. Post hoc analysis of data from patients with a large prostate volume or severe lower urinary tract symptoms was based on analysis A-in 62 of 279 participants (22.3%) (monopolar transurethral prostate resection 32, bipolar transurethral prostate resection 30) or analysis B-in 126 of 279 participants (45.2%) (monopolar transurethral prostate resection 57, bipolar transurethral prostate resection 69). Mean (SD) prostate volume was 108.0 (25.9) ml for monopolar transurethral prostate resection and 108.9 (23.4) ml for bipolar transurethral prostate resection (p=0.756). Mean International Prostate Symptom Score was 25.0 (4.2) for monopolar transurethral prostate resection and 25.3 (3.7) for bipolar transurethral prostate resection (p=0.402). Neither safety nor any secondary outcome differed significantly between the arms throughout followup. The only exception was the decrease in sodium (analysis A), which was significantly greater after monopolar transurethral prostate resection (-4.2 vs -0.7 mmol/l, p=0.023) and did not translate into a significant difference in transurethral resection syndrome rates (monopolar transurethral prostate resection 1 of 32 vs bipolar transurethral prostate resection 0 of 30, p=1.000). CONCLUSIONS: Bipolar and monopolar transurethral prostate resection show similar safety/efficacy in these patient subpopulations.